BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31641030)

  • 1. A Model of Indirect Cell Death Caused by Tumor Vascular Damage after High-Dose Radiotherapy.
    Rodríguez-Barbeito P; Díaz-Botana P; Gago-Arias A; Feijoo M; Neira S; Guiu-Souto J; López-Pouso Ó; Gómez-Caamaño A; Pardo-Montero J
    Cancer Res; 2019 Dec; 79(23):6044-6053. PubMed ID: 31641030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
    Brown JM; Carlson DJ; Brenner DJ
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):254-62. PubMed ID: 24411596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiological basis of SBRT and SRS.
    Song CW; Kim MS; Cho LC; Dusenbery K; Sperduto PW
    Int J Clin Oncol; 2014 Aug; 19(4):570-8. PubMed ID: 24993673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
    Guerrero M; Li XA
    Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death.
    Song CW; Glatstein E; Marks LB; Emami B; Grimm J; Sperduto PW; Kim MS; Hui S; Dusenbery KE; Cho LC
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):21-34. PubMed ID: 30836165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A voxel-based multiscale model to simulate the radiation response of hypoxic tumors.
    Espinoza I; Peschke P; Karger CP
    Med Phys; 2015 Jan; 42(1):90-102. PubMed ID: 25563250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
    Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
    Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.
    Castle KD; Kirsch DG
    Cancer Res; 2019 Nov; 79(22):5685-5692. PubMed ID: 31427377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.
    Tubin S; Popper HH; Brcic L
    Radiat Oncol; 2019 Jan; 14(1):21. PubMed ID: 30696472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia.
    Ruggieri R
    Phys Med Biol; 2004 Oct; 49(20):4811-23. PubMed ID: 15566177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modified linear-quadratic model of Guerrero and Li can be derived from a mechanistic basis and exhibits linear-quadratic-linear behaviour.
    Carlone M; Wilkins D; Raaphorst P
    Phys Med Biol; 2005 May; 50(10):L9-13; author reply L13-5. PubMed ID: 15876677
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved cellular automata model shows that indirect apoptotic cell death due to vascular damage enhances the local control of tumors by single fraction high-dose irradiation.
    Kawahara D; Nagata Y; Watanabe Y
    Biomed Phys Eng Express; 2021 Dec; 8(1):. PubMed ID: 34920444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The radiobiology of hypofractionation.
    Nahum AE
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypofractionation: non-homogeneous tumour dose delivery can counteract tumour hypoxia.
    Ruggieri R; Naccarato S; Nahum AE
    Acta Oncol; 2010 Nov; 49(8):1304-14. PubMed ID: 20500031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbeam radiation-induced tissue damage depends on the stage of vascular maturation.
    Sabatasso S; Laissue JA; Hlushchuk R; Graber W; Bravin A; Bräuer-Krisch E; Corde S; Blattmann H; Gruber G; Djonov V
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1522-32. PubMed ID: 21740994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of high-dose irradiation on vascularization: Physiopathology and clinical consequences].
    Nivet A; Schlienger M; Clavère P; Huguet F
    Cancer Radiother; 2019 Apr; 23(2):161-167. PubMed ID: 30922894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).
    Park HJ; Griffin RJ; Hui S; Levitt SH; Song CW
    Radiat Res; 2012 Mar; 177(3):311-27. PubMed ID: 22229487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
    Shibamoto Y; Otsuka S; Iwata H; Sugie C; Ogino H; Tomita N
    J Radiat Res; 2012; 53(1):1-9. PubMed ID: 21997195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiobiology dedicated to endothelium].
    Supiot S; Paris F
    Cancer Radiother; 2012 Feb; 16(1):11-5. PubMed ID: 22326117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.
    Ruggieri R; Stavreva N; Naccarato S; Stavrev P
    Phys Med Biol; 2013 Jul; 58(13):4611-20. PubMed ID: 23771131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.